| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 10/19/2004 | US6806024 Oxime derivatives and the use thereof as photoinitiators |
| 10/14/2004 | WO2004087061A2 Tubulin binding agents and corresponding prodrug constructs |
| 10/14/2004 | WO2004056727A3 Process of making chalcone derivatives |
| 10/14/2004 | US20040204591 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group |
| 10/14/2004 | US20040204502 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 10/14/2004 | US20040204494 Having anticancer, anti-proliferous and anti-inflammatory effects and immunosuppressive and muscle relaxing functions |
| 10/14/2004 | US20040204477 For use as antiproliferative agents |
| 10/13/2004 | EP1466898A1 Beta-amyloid protein production/secretion inhibitors |
| 10/13/2004 | EP1466891A1 Carboxylic acid derivative |
| 10/13/2004 | EP1466625A1 Preventives/remedies for urinary disturbance |
| 10/13/2004 | EP1465884A1 Catalyst and process for the oxidation of hydrocarbons |
| 10/13/2004 | EP1465883A1 Conversion of tetrahydroxybutane to tetrahydrofuran |
| 10/13/2004 | EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 10/13/2004 | EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 10/13/2004 | EP1465854A2 Chalcone derivatives and their use to treat diseases |
| 10/13/2004 | EP1465726A1 Process for preparing nonracemic chiral alcohols |
| 10/13/2004 | EP1465638A2 Phosphate transport inhibitors |
| 10/13/2004 | EP1465623A1 Urea derivatives |
| 10/13/2004 | EP1372807B1 Ionic liquids as selective additives for the separation of close-boiling or azeotropic mixtures |
| 10/13/2004 | EP1165533B1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 10/13/2004 | EP0999204B1 Novel compound having effect of promoting neuron differentiation |
| 10/13/2004 | CN1537107A Process for production of beraprost and its salts |
| 10/13/2004 | CN1537106A Method for producing maleic anhydride |
| 10/13/2004 | CN1537093A Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 10/13/2004 | CN1537001A Malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 10/13/2004 | CN1536997A Crystalline composition containing escitalopram |
| 10/13/2004 | CN1536996A (-)-olivil as antioxidant |
| 10/13/2004 | CN1536994A Hypoglycemic agent |
| 10/13/2004 | CN1536992A Carbamates of 2-heterocyclic-1, 2-ethanediols |
| 10/13/2004 | CN1535956A Substituted phenyl keto-enol pesticide and weedicide |
| 10/13/2004 | CN1170813C N2 phenylamidine derivatives and fungicidal composition and use |
| 10/12/2004 | US6803473 Method for producing maleic acid anhydride |
| 10/12/2004 | US6803388 Treating atherosclerosis and coronary artery diseases; stereoselective; chemical intermediates |
| 10/12/2004 | US6803384 Diaminopropionic acid derivatives |
| 10/12/2004 | US6803378 For therapy and prophylaxis of acquired immune deficiency syndrome (aids), or arc |
| 10/12/2004 | US6803372 Such as cis-n-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'h)-isobenzofuran)-4-carboxamide for use as neuropeptide y receptor antagonist for treatment bulimia, obesity or diabetes |
| 10/12/2004 | US6803362 Heterocyclic compounds |
| 10/07/2004 | WO2004085458A2 Steroid spirolactonization |
| 10/07/2004 | WO2004085417A1 Novel sesquiterpene oxides as perfuming and flavouring agents |
| 10/07/2004 | WO2004085416A1 Novel crystalline forms of (s)-citalopram oxalate |
| 10/07/2004 | WO2004085414A1 Process to produce enantiomerically enriched 1-aryl- and 1-heteroaryl-2-aminoethanols |
| 10/07/2004 | WO2004085385A2 Cannabinoid receptor ligands |
| 10/07/2004 | WO2004085382A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same |
| 10/07/2004 | WO2004084842A2 Inhibitors of cathepsin s |
| 10/07/2004 | WO2004060987A3 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents |
| 10/07/2004 | WO2004047738A3 Arylcyclopropylcarboxylic amides as potassium channel openers |
| 10/07/2004 | US20040199026 Process for the production of ethers, typically thf |
| 10/07/2004 | US20040199010 High-purity biphenyltetracarboxylic dianhydride and process for producing the same |
| 10/07/2004 | US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis |
| 10/07/2004 | US20040198980 Selective rxr ligands |
| 10/07/2004 | US20040198820 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 10/07/2004 | US20040198814 prevention , therapy of cardiovascular disorders, dyslipidemias, glucose metabolism, hypoglycemic agents; reduce fat concentration in meat; reduce cholesterol concentration in eggs |
| 10/07/2004 | US20040198811 Use of enantiomeric pure escitalopram |
| 10/07/2004 | US20040198810 Use of enantiomeric pure escitalopram |
| 10/07/2004 | US20040198809 Use of enantiomeric pure escitalopram |
| 10/07/2004 | US20040198808 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 10/07/2004 | US20040198780 osteoporosis; antiarthritic agents; antidiabetic aghents; Alzheimer's disease; shock; central nervous system disorders; anticancer agents |
| 10/07/2004 | US20040198779 Antiinflammatory agents; adult respiratory distress syndrome |
| 10/07/2004 | US20040198733 Obesity; antidiabetic agents; cardiovascular disorders; antilipemic agentsl circadian rhythm disorders; hypotensive agents; antidepressants; anxiolytic agents |
| 10/07/2004 | US20040198732 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals |
| 10/07/2004 | US20040198731 Antidiabetic agents; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents; circidian rhythm disorders |
| 10/07/2004 | US20040198716 Cysteine protease inhimbitors |
| 10/07/2004 | US20040198596 Using catalyst comprising copper oxide, palladium or palladium compound on catalyst support of an oxide of aluminum, silicon, zinc, lanthanum, cerium, groups 3A, 8, 1A, and/or 2A; cyclization, lactonization, etherification, esterification |
| 10/07/2004 | CA2520055A1 Process to produce enantiomerically enriched 1-aryl- and 1-heteroaryl-2-aminoethanols |
| 10/07/2004 | CA2519770A1 Steroid spirolactonization |
| 10/07/2004 | CA2519401A1 Cannabinoid receptor ligands |
| 10/06/2004 | EP1463722A2 PREPARATION OF CIS-FUSED 3,3a,8,12b-TETRAHYDRO-2-H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURAN DERIVATIVES |
| 10/06/2004 | EP1463721A1 Compounds for imaging alzheimer's disease |
| 10/06/2004 | EP1463720A1 Systems and methods for generation of ascorbic acid with reduced color |
| 10/06/2004 | EP1463715A1 Novel glucagon antagonists |
| 10/06/2004 | EP1463714A2 Vanilloid receptor ligands and their use in treatments |
| 10/06/2004 | EP1463713A1 Prodrugs of excitatory amino acids |
| 10/06/2004 | EP1278752B1 Improved synthesis of anhydroglycitol esters of improved colour |
| 10/06/2004 | EP1232141B1 Ethers of o-desmethyl venlafaxine |
| 10/06/2004 | EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 10/06/2004 | EP1101755B1 Anthranilic acid derivatives |
| 10/06/2004 | EP1098864B1 Method for hydrogenating unsaturated heterocyclic compounds |
| 10/06/2004 | EP1080082B1 Intermediates for the synthesis of epothilones and methods for their preparation |
| 10/06/2004 | CN1535270A Tetrahydropyridazine derivatives and their use as pesticides |
| 10/06/2004 | CN1534033A Preparation method of 3-methylfuran |
| 10/06/2004 | CN1534023A Heterocyclic compound as dopamine-D3ligand |
| 10/06/2004 | CN1534016A Calcium acceptor active compound |
| 10/06/2004 | CN1534010A Water soluble extract of red sage root and its preeparation method and use |
| 10/06/2004 | CN1534007A Method of large scale preparing single protected cis-1,4-butenediol derivative |
| 10/06/2004 | CN1533836A Vanadium/phosphorus mixed oxide catalyst precusor, active catalyst for preparing maleic anhydride and method of preparing maleic anhydride |
| 10/06/2004 | CN1169805C Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products |
| 10/06/2004 | CN1169803C Production process of high-purity chuanhuning |
| 10/06/2004 | CN1169802C Corter pseudolaricis acetic acid composition and its preparing process |
| 10/06/2004 | CN1169771C 3-substituted 5,6,7,8 tetrahydro-4a, 8a method-2-keto-naphthalene, synthesis method and use thereof |
| 10/05/2004 | US6800769 Chemical intermediates |
| 10/05/2004 | US6800766 Catalyzing the decyclization of racemic and diastereomeric epoxides mixtures in the presence of a non-racemic, chiral catalyst; pharmaceutical synthesis |
| 10/05/2004 | US6800660 Bis(thio-hydrazide amide) compounds; anticancer agents |
| 10/05/2004 | US6800656 Tricyclic compounds and method of treating herpes virus |
| 10/05/2004 | CA2282834C Novel hexanoic acid derivatives |
| 10/05/2004 | CA2103836C 7-(substituted)-9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines |
| 09/30/2004 | WO2004083197A2 Intermediates for the preparation of citalopram and escitalopram |
| 09/30/2004 | WO2004082677A1 Substituted p-diaminobenzene derivatives |
| 09/30/2004 | WO2003072535A8 Substituted hydroxyethylamines |
| 09/30/2004 | WO2003022785A3 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 09/30/2004 | US20040192960 Process for the optical resolution of a precursor of sclareolide |